# Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of Hyperkalaemia

> **NCT04864795** · — · COMPLETED · sponsor: **Vifor (International) Inc.** · enrollment: 2636 (actual)

## Conditions studied

- Heart Failure
- Hyperkalemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04864795
- **Lead sponsor:** Vifor (International) Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-19
- **Primary completion:** 2024-02-29
- **Final completion:** 2024-08-30
- **Target enrollment:** 2636 (ACTUAL)
- **Last updated:** 2024-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04864795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04864795, "Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of Hyperkalaemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04864795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*